Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2024		2023
Numerator:
Net loss	$	(101,802)	$	(109,781)

Denominator:
Weighted average number of:
Common stock shares outstanding	140,245,132		136,524,528
Private placement pre-funded warrants	9,159,056		—
Total	149,404,188		136,524,528
Net loss per share	$	(0.68)	$	(0.80)

Potentially dilutive securities, including all options issued and outstanding, ESPP shares issuable, and restricted shares subject to future vesting that were not included in the diluted per share calculations for all periods presented because they would be anti-dilutive totaled approximately 24.4 million and 21.4 million shares as of March 31, 2024 and March 31, 2023, respectively.